We are live on
!
Find out more
Walleye Capital Portfolio holdings
AUM
$24B
1-Year Est. Return
37.67%
This Fund
S&P 500
This Quarter
Est. Return
-0.19%
1 Year Est. Return
+37.67%
3 Year Est. Return
+98.01%
5 Year Est. Return
+160%
10 Year Est. Return
–
AUM
$24B
AUM Growth
-$8.57B
(-26%)
Cap. Flow
-$8.5B
Cap. Flow
% of AUM
-35.37%
Top 10 Holdings %
Top 10 Hldgs %
32.92%
Holding
5,150
New
660
Increased
1,270
Reduced
2,242
Closed
835
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$948M |
| 2 |
Amazon
AMZN
|
+$264M |
| 3 |
iShares Bitcoin Trust
IBIT
|
+$138M |
| 4 |
Apple
AAPL
|
+$111M |
| 5 |
Doximity
DOCS
|
+$72.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$778M |
| 2 |
Intuitive Surgical
ISRG
|
+$110M |
| 3 |
Boston Scientific
BSX
|
+$96.4M |
| 4 |
Cummins
CMI
|
+$90.4M |
| 5 |
Microsoft
MSFT
|
+$77.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.1% |
| 2 | Consumer Discretionary | 7.52% |
| 3 | Industrials | 5.58% |
| 4 | Financials | 4.45% |
| 5 | Healthcare | 4.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3876
CRISPR Therapeutics
CRSP
$4.6B
| $43.5K | ﹤0.01% |
+915
| New | +$48.3K |
|
3877
PUT
Hertz
HTZ
$632M
| $43.3K | ﹤0.01% |
9,400
+8,600
| +1,075% | +$41.6K |
|
3878
Clover Health Investments
CLOV
$2.25B
| $43.1K | ﹤0.01% |
24,512
-82,689
| -77% | -$179K |
|
3879
PUT
Expeditors International
EXPD
$22.4B
| $43K | ﹤0.01% |
300
-300
| -50% | -$45.6K |
|
3880
Leidos
LDOS
$14.5B
| $42.8K | ﹤0.01% |
+275
| New | +$49.4K |
|
|
HVIIR
3881
Hennessy Capital Investment Corp VII Rights
HVIIR
| $42.7K | ﹤0.01% |
149,884
-1,000
| -0.7% | -$276 |
|
3882
CALL
Tenable Holdings
TENB
$3.58B
| $42.3K | ﹤0.01% |
+2,500
| New | +$52.5K |
|
3883
PUT
Shoals Technologies Group
SHLS
$1.57B
| $42.1K | ﹤0.01% |
6,400
-66,800
| -91% | -$548K |
|
3884
PUT
AvePoint
AVPT
$2.72B
| $41.8K | ﹤0.01% |
+4,400
| New | +$49.6K |
|
3885
W.R. Berkley
WRB
$28.1B
| $41.4K | ﹤0.01% |
625
-5,432
| -90% | -$374K |
|
3886
CALL
Ryder
R
$10.3B
| $40.9K | ﹤0.01% |
+200
| New | +$40.4K |
|
3887
PUT
Liberty Energy
LBRT
$2.75B
| $40.3K | ﹤0.01% |
1,400
+800
| +133% | +$20.4K |
|
3888
Corcept Therapeutics
CORT
$9.78B
| $40.3K | ﹤0.01% |
1,000
-179,401
| -99% | -$6.71M |
|
3889
Aecom
ACM
$9.12B
| $40.3K | ﹤0.01% |
475
-226
| -32% | -$21.4K |
|
3890
Remitly
RELY
$4.77B
| $40.2K | ﹤0.01% |
2,567
+2,565
| +128,250% | +$38K |
|
|
ESPR
3891
PUT
DELISTED
Esperion Therapeutics
ESPR
| $40K | ﹤0.01% |
14,600
-161,700
| -92% | -$512K |
|
3892
PUT
Amdocs
DOX
$5.64B
| $39.2K | ﹤0.01% |
+600
| New | +$43.9K |
|
3893
CALL
Fiverr
FVRR
$398M
| $39.1K | ﹤0.01% |
3,900
-2,100
| -35% | -$28.9K |
|
3894
PUT
Star Bulk Carriers
SBLK
$3.02B
| $39K | ﹤0.01% |
1,700
-2,300
| -58% | -$52.4K |
|
3895
Travelers Companies
TRV
$81.4B
| $38.8K | ﹤0.01% |
133
+132
| +13,200% | +$38.7K |
|
3896
Exelixis
EXEL
$14B
| $38.8K | ﹤0.01% |
904
-154,939
| -99% | -$6.66M |
|
3897
CALL
Newell Brands
NWL
$2.2B
| $38.8K | ﹤0.01% |
11,300
-109,000
| -91% | -$458K |
|
3898
PUT
ICU Medical
ICUI
$4.04B
| $38.7K | ﹤0.01% |
+300
| New | +$43.1K |
|
3899
Allegiant Air
ALGT
$2.66B
| $38.7K | ﹤0.01% |
+478
| New | +$44K |
|
|
SKYAW
3900
SkyAI Inc
SKYAW
$249K
| $38.5K | ﹤0.01% |
1,045,368
| – | – |
|
Similar funds
JG
SC
OAG
CS
Walleye Capital's Q1 2026 Portfolio in Review
As of Q1 2026, Walleye Capital held 5,150 positions worth $24B, down 26% from $32.6B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Walleye Capital withdrew a net $8.5B in Q1 2026, closing 835 positions and reducing 2,242 holdings. Its most notable exit was Repligen, an estimated $68.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.1% of assets, up from 7.3% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Walleye Capital opened a new position in Texas Roadhouse worth $51.4M.
- Walleye Capital's largest Q1 2026 buy was Texas Roadhouse: 311,416 shares worth $51.4M.
- Walleye Capital added most to State Street SPDR S&P 500 ETF Trust in Q1 2026, an estimated $948M increase.
- Walleye Capital's biggest Q1 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $778M.
- Walleye Capital fully exited Repligen in Q1 2026, selling an estimated $68.3M.
- Walleye Capital's ten largest holdings make up 33% of its $24B portfolio in Q1 2026.
- Walleye Capital opened 660 new positions and closed 835 in Q1 2026.
- Walleye Capital's portfolio value fell 26% quarter-over-quarter to $24B.
Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.